Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.

Ansari A, Maffioletti E, Milanesi E, Marizzoni M, Frisoni GB, Blin O, Richardson JC, Bordet R, Forloni G, Gennarelli M, Bocchio-Chiavetto L; PharmaCog Consortium.

Neurobiol Aging. 2019 Jun 21;82:102-109. doi: 10.1016/j.neurobiolaging.2019.06.005. [Epub ahead of print]

PMID:
31437718
2.

Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates.

Vita A, Minelli A, Barlati S, Deste G, Giacopuzzi E, Valsecchi P, Turrina C, Gennarelli M.

Front Pharmacol. 2019 Apr 16;10:402. doi: 10.3389/fphar.2019.00402. eCollection 2019. Review.

3.

BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.

Maffioletti E, Gennarelli M, Gainelli G, Bocchio-Chiavetto L, Bortolomasi M, Minelli A.

J ECT. 2019 Feb 26. doi: 10.1097/YCT.0000000000000583. [Epub ahead of print]

PMID:
30994478
4.

α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?

Filippini A, Gennarelli M, Russo I.

Cell Mol Neurobiol. 2019 Mar;39(2):161-168. doi: 10.1007/s10571-019-00649-9. Epub 2019 Jan 14. Review.

PMID:
30637614
5.

Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables.

Giacopuzzi E, Gennarelli M, Sacco C, Filippini A, Mingardi J, Magri C, Barbon A.

BMC Genomics. 2018 Dec 27;19(1):963. doi: 10.1186/s12864-018-5364-8.

6.

Next Generation Sequencing Analysis in Early Onset Dementia Patients.

Bonvicini C, Scassellati C, Benussi L, Di Maria E, Maj C, Ciani M, Fostinelli S, Mega A, Bocchetta M, Lanzi G, Giacopuzzi E, Ferraboli S, Pievani M, Fedi V, Defanti CA, Giliani S; Alzheimer’s Disease Neuroimaging Initiative, Frisoni GB, Ghidoni R, Gennarelli M.

J Alzheimers Dis. 2019;67(1):243-256. doi: 10.3233/JAD-180482.

7.

A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme.

Magri C, Giacopuzzi E, La Via L, Bonini D, Ravasio V, Elhussiny MEA, Orizio F, Gangemi F, Valsecchi P, Bresciani R, Barbon A, Vita A, Gennarelli M.

Sci Rep. 2018 Oct 19;8(1):15470. doi: 10.1038/s41598-018-33924-8.

8.

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients.

Roulot M, Minelli A, Bortolomasi M, Maffioletti E, Gennarelli M, Borsotto M, Heurteaux C, Mazella J.

Neuropsychiatr Dis Treat. 2018 Sep 6;14:2307-2312. doi: 10.2147/NDT.S170165. eCollection 2018.

9.

The effect of childhood trauma on blood transcriptome expression in major depressive disorder.

Minelli A, Magri C, Giacopuzzi E, Gennarelli M.

J Psychiatr Res. 2018 Sep;104:50-54. doi: 10.1016/j.jpsychires.2018.06.014. Epub 2018 Jun 26.

PMID:
29975859
10.

Enhancing HIV Pre-exposure Prophylaxis Practices via an Educational Intervention.

Newman R, Katchi T, Karass M, Gennarelli M, Goutis J, Kifayat A, Solanki S, Yandrapalli S, Forman L, Nabors C.

Am J Ther. 2019 Jul/Aug;26(4):e462-e468. doi: 10.1097/MJT.0000000000000773.

PMID:
29683840
11.

Immune and metabolic alterations in first episode psychosis (FEP) patients.

Bocchio-Chiavetto L, Zanardini R, Tosato S, Ventriglia M, Ferrari C, Bonetto C, Lasalvia A, Giubilini F, Fioritti A, Pileggi F, Pratelli M, Pavanati M, Favaro A, De Girolamo G, Frisoni GB, Ruggeri M, Gennarelli M; GET UP Group.

Brain Behav Immun. 2018 May;70:315-324. doi: 10.1016/j.bbi.2018.03.013. Epub 2018 Mar 13.

PMID:
29548996
12.

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.

Collo G, Cavalleri L, Bono F, Mora C, Fedele S, Invernizzi RW, Gennarelli M, Piovani G, Kunath T, Millan MJ, Merlo Pich E, Spano P.

Neural Plast. 2018 Feb 4;2018:4196961. doi: 10.1155/2018/4196961. eCollection 2018.

13.

Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes.

Maffioletti E, Salvi A, Conde I, Maj C, Gennarelli M, De Petro G, Bocchio-Chiavetto L.

Mol Cell Neurosci. 2017 Dec;85:220-225. doi: 10.1016/j.mcn.2017.10.005. Epub 2017 Oct 25.

PMID:
29079539
14.

Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways.

Giacopuzzi E, Gennarelli M, Minelli A, Gardella R, Valsecchi P, Traversa M, Bonvicini C, Vita A, Sacchetti E, Magri C.

PLoS One. 2017 Aug 7;12(8):e0182778. doi: 10.1371/journal.pone.0182778. eCollection 2017.

15.

Milestones: a rapid assessment method for the Clinical Competency Committee.

Nabors C, Forman L, Peterson SJ, Gennarelli M, Aronow WS, DeLorenzo L, Chandy D, Ahn C, Sule S, Stallings GW, Khera S, Palaniswamy C, Frishman WH.

Arch Med Sci. 2017 Feb 1;13(1):201-209. doi: 10.5114/aoms.2016.64045. Epub 2016 Nov 29.

16.

Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.

Bono F, Savoia P, Guglielmi A, Gennarelli M, Piovani G, Sigala S, Leo D, Espinoza S, Gainetdinov RR, Devoto P, Spano P, Missale C, Fiorentini C.

Mol Neurobiol. 2018 Feb;55(2):1054-1067. doi: 10.1007/s12035-016-0376-3. Epub 2017 Jan 14.

PMID:
28092083
17.

Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues.

Milanesi E, Zanardini R, Rosso G, Maina G, Barbon A, Mora C, Minelli A, Gennarelli M, Bocchio-Chiavetto L.

World J Biol Psychiatry. 2018 Dec;19(8):610-618. doi: 10.1080/15622975.2017.1282172. Epub 2017 Feb 15.

18.

Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia.

Gardella R, Sacchetti E, Legati A, Magri C, Traversa M, Gennarelli M.

Psychiatry Res. 2017 Dec;258:598-599. doi: 10.1016/j.psychres.2016.10.057. Epub 2016 Oct 29. No abstract available.

PMID:
28043646
19.

Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients.

Devader C, Roulot M, Moréno S, Minelli A, Bortolomasi M, Congiu C, Gennarelli M, Borsotto M, Heurteaux C, Mazella J.

J Affect Disord. 2017 Jan 15;208:443-447. doi: 10.1016/j.jad.2016.10.049. Epub 2016 Nov 4.

PMID:
27838145
20.

Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study.

Rosso G, Zanardini R, Chiodelli DF, Ferrari C, Gennarelli M, Bocchio-Chiavetto L.

Neuropsychobiology. 2016;74(1):15-21. doi: 10.1159/000446918. Epub 2016 Jul 27.

21.

The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia.

Maj C, Minelli A, Giacopuzzi E, Sacchetti E, Gennarelli M.

Curr Neuropharmacol. 2016;14(5):540-50. Review.

22.

Influence of GRIK4 genetic variants on the electroconvulsive therapy response.

Minelli A, Congiu C, Ventriglia M, Bortolomasi M, Bonvicini C, Abate M, Sartori R, Gainelli G, Gennarelli M.

Neurosci Lett. 2016 Jul 28;626:94-8. doi: 10.1016/j.neulet.2016.05.030. Epub 2016 May 17.

PMID:
27222927
23.

Peripheral whole blood microRNA alterations in major depression and bipolar disorder.

Maffioletti E, Cattaneo A, Rosso G, Maina G, Maj C, Gennarelli M, Tardito D, Bocchio-Chiavetto L.

J Affect Disord. 2016 Aug;200:250-8. doi: 10.1016/j.jad.2016.04.021. Epub 2016 Apr 20.

24.

Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation.

Bonini D, Mora C, Tornese P, Sala N, Filippini A, La Via L, Milanese M, Calza S, Bonanno G, Racagni G, Gennarelli M, Popoli M, Musazzi L, Barbon A.

Neural Plast. 2016;2016:7267865. doi: 10.1155/2016/7267865. Epub 2016 Feb 4.

25.

Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.

Bocchetta M, Mega A, Bernardi L, Di Maria E, Benussi L, Binetti G, Borroni B, Colao R, Di Fede G, Fostinelli S, Galimberti D, Gennarelli M, Ghidoni R, Piaceri I, Pievani M, Porteri C, Redaelli V, Rossi G, Suardi S, Babiloni C, Scarpini E, Tagliavini F, Padovani A, Nacmias B, Sorbi S, Frisoni GB, Bruni AC; SINdem Collaborators.

J Alzheimers Dis. 2016;51(1):277-91. doi: 10.3233/JAD-150849.

PMID:
26901402
26.

The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.

Sacchetti E, Magri C, Minelli A, Valsecchi P, Traversa M, Calza S, Vita A, Gennarelli M.

Pharmacogenomics J. 2017 Mar;17(2):146-154. doi: 10.1038/tpj.2015.90. Epub 2016 Feb 9.

PMID:
26856250
27.

Erratum to: Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Squitti R, Ventriglia M, Gennarelli M, Colabufo NA, El Idrissi IG, Bucossi S, Mariani S, Rongioletti M, Zanetti O, Congiu C, Rossini PM, Bonvicini C.

Mol Neurobiol. 2017 Jan;54(1):682-683. doi: 10.1007/s12035-016-9734-4. No abstract available.

PMID:
26819212
28.

Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Squitti R, Ventriglia M, Gennarelli M, Colabufo NA, El Idrissi IG, Bucossi S, Mariani S, Rongioletti M, Zanetti O, Congiu C, Rossini PM, Bonvicini C.

Mol Neurobiol. 2017 Jan;54(1):671-681. doi: 10.1007/s12035-015-9664-6. Epub 2016 Jan 12. Erratum in: Mol Neurobiol. 2017 Jan;54(1):682-683.

PMID:
26758278
29.

Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.

Minelli A, Magri C, Barbon A, Bonvicini C, Segala M, Congiu C, Bignotti S, Milanesi E, Trabucchi L, Cattane N, Bortolomasi M, Gennarelli M.

Transl Psychiatry. 2015 Dec 1;5:e687. doi: 10.1038/tp.2015.180.

30.

Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response.

Minelli A, Abate M, Zampieri E, Gainelli G, Trabucchi L, Segala M, Sartori R, Gennarelli M, Conca A, Bortolomasi M.

J ECT. 2016 Jun;32(2):88-92. doi: 10.1097/YCT.0000000000000274.

PMID:
26397151
31.

The role of GRIK4 gene in treatment-resistant depression.

Milanesi E, Bonvicini C, Congiu C, Bortolomasi M, Gainelli G, Gennarelli M, Minelli A.

Genet Res (Camb). 2015 Jul 3;97:e14. doi: 10.1017/S0016672315000142.

PMID:
26139080
32.

Glucose metabolism alterations in patients with bipolar disorder.

Rosso G, Cattaneo A, Zanardini R, Gennarelli M, Maina G, Bocchio-Chiavetto L.

J Affect Disord. 2015 Sep 15;184:293-8. doi: 10.1016/j.jad.2015.06.006. Epub 2015 Jun 16.

33.

MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder.

Gabriela Nielsen M, Congiu C, Bortolomasi M, Bonvicini C, Bignotti S, Abate M, Milanesi E, Conca A, Cattane N, Tessari E, Gennarelli M, Minelli A.

J Affect Disord. 2015 Sep 1;183:179-86. doi: 10.1016/j.jad.2015.05.003. Epub 2015 May 11.

PMID:
26021967
34.

Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients.

Milanesi E, Hadar A, Maffioletti E, Werner H, Shomron N, Gennarelli M, Schulze TG, Costa M, Del Zompo M, Squassina A, Gurwitz D.

J Mol Neurosci. 2015 Jul;56(3):681-7. doi: 10.1007/s12031-015-0523-8. Epub 2015 Mar 5.

PMID:
25740013
35.

Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood.

Cattane N, Minelli A, Milanesi E, Maj C, Bignotti S, Bortolomasi M, Bocchio Chiavetto L, Gennarelli M.

PLoS One. 2015 Feb 6;10(2):e0116686. doi: 10.1371/journal.pone.0116686. eCollection 2015.

36.

The role of the potassium channel gene KCNK2 in major depressive disorder.

Congiu C, Minelli A, Bonvicini C, Bortolomasi M, Sartori R, Maj C, Scassellati C, Maina G, Trabucchi L, Segala M, Gennarelli M.

Psychiatry Res. 2015 Feb 28;225(3):489-92. doi: 10.1016/j.psychres.2014.11.061. Epub 2014 Dec 9.

37.

Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role.

Valbonesi S, Magri C, Traversa M, Faraone SV, Cattaneo A, Milanesi E, Valenti V, Gennarelli M, Scassellati C.

Psychiatr Genet. 2015 Apr;25(2):59-70. doi: 10.1097/YPG.0000000000000056.

PMID:
25370694
38.

Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum.

Maffioletti E, Zanardini R, Gennarelli M, Bocchio-Chiavetto L.

Biotechniques. 2014;57(3):111-4. No abstract available.

39.

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders.

Maffioletti E, Tardito D, Gennarelli M, Bocchio-Chiavetto L.

Front Cell Neurosci. 2014 Mar 11;8:75. doi: 10.3389/fncel.2014.00075. eCollection 2014. Review.

40.

Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation.

Bonvicini C, Milanesi E, Pilotto A, Cattane N, Premi E, Archetti S, Padovani A, Gennarelli M, Borroni B.

Neurobiol Aging. 2014 May;35(5):1206-11. doi: 10.1016/j.neurobiolaging.2013.10.097. Epub 2013 Nov 1.

PMID:
24368088
41.

Heterozygous TREM2 mutations in frontotemporal dementia.

Borroni B, Ferrari F, Galimberti D, Nacmias B, Barone C, Bagnoli S, Fenoglio C, Piaceri I, Archetti S, Bonvicini C, Gennarelli M, Turla M, Scarpini E, Sorbi S, Padovani A.

Neurobiol Aging. 2014 Apr;35(4):934.e7-10. doi: 10.1016/j.neurobiolaging.2013.09.017. Epub 2013 Oct 16.

42.

Serum brain-derived neurotrophic factor levels in different neurological diseases.

Ventriglia M, Zanardini R, Bonomini C, Zanetti O, Volpe D, Pasqualetti P, Gennarelli M, Bocchio-Chiavetto L.

Biomed Res Int. 2013;2013:901082. doi: 10.1155/2013/901082. Epub 2013 Aug 19.

43.

Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.

Minelli A, Maffioletti E, Bortolomasi M, Conca A, Zanardini R, Rillosi L, Abate M, Giacopuzzi M, Maina G, Gennarelli M, Bocchio-Chiavetto L.

Acta Psychiatr Scand. 2014 Jun;129(6):461-6. doi: 10.1111/acps.12187. Epub 2013 Aug 20.

44.

Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders.

Minelli A, Maffioletti E, Cloninger CR, Magri C, Sartori R, Bortolomasi M, Congiu C, Bignotti S, Segala M, Giacopuzzi M, Gennarelli M.

Depress Anxiety. 2013 Dec;30(12):1170-6. doi: 10.1002/da.22158. Epub 2013 Jul 16.

PMID:
23861224
45.

Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD).

Scassellati C, Zanardini R, Tiberti A, Pezzani M, Valenti V, Effedri P, Filippini E, Conte S, Ottolini A, Gennarelli M, Bocchio-Chiavetto L.

Eur Child Adolesc Psychiatry. 2014 Mar;23(3):173-7. doi: 10.1007/s00787-013-0447-1. Epub 2013 Jun 28.

PMID:
23812866
46.

Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis.

Anacker C, Cattaneo A, Musaelyan K, Zunszain PA, Horowitz M, Molteni R, Luoni A, Calabrese F, Tansey K, Gennarelli M, Thuret S, Price J, Uher R, Riva MA, Pariante CM.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8708-13. doi: 10.1073/pnas.1300886110. Epub 2013 May 6.

47.

Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.

Sacchetti E, Scassellati C, Minelli A, Valsecchi P, Bonvicini C, Pasqualetti P, Galluzzo A, Pioli R, Gennarelli M.

BMC Med Genet. 2013 Mar 9;14:33. doi: 10.1186/1471-2350-14-33.

48.

Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study.

Milanesi E, Bonvicini C, Alberici A, Pilotto A, Cattane N, Premi E, Gazzina S, Archetti S, Gasparotti R, Cancelli V, Gennarelli M, Padovani A, Borroni B.

Neurobiol Aging. 2013 Jul;34(7):1837-45. doi: 10.1016/j.neurobiolaging.2012.11.016. Epub 2013 Feb 15.

PMID:
23419701
49.

Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis.

Anacker C, Cattaneo A, Luoni A, Musaelyan K, Zunszain PA, Milanesi E, Rybka J, Berry A, Cirulli F, Thuret S, Price J, Riva MA, Gennarelli M, Pariante CM.

Neuropsychopharmacology. 2013 Apr;38(5):872-83. doi: 10.1038/npp.2012.253. Epub 2012 Dec 6.

50.

Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses.

Scassellati C, Bonvicini C, Faraone SV, Gennarelli M.

J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):1003-1019.e20. doi: 10.1016/j.jaac.2012.08.015. Review.

PMID:
23021477

Supplemental Content

Loading ...
Support Center